Abstract:Metabolic syndrome (MetS) disorders such as diabetes increase the risk of developing age‐related dementia. The present study shows that the KKAy mouse model of MetS develops cognitive impairments that are concomitant with pathological tau and reduced O‐GlcNAc signaling in the brain. Metabolic syndrome (MetS), characterized by hyperglycemia, obesity, and hyperlipidemia, can increase the risk of developing late‐onset dementia. Recent studies in patients and mouse models suggest a putative link between hyperphosphorylated tau, a component of Alzheimer's disease‐related dementia (ADRD) pathology, and cerebral glucose hypometabolism. Impaired glucose metabolism reduces glucose flux through the hexosamine metabolic pathway triggering attenuated O‐linked N‐acetylglucosamine (O‐GlcNAc) protein modification. The goal of the current study was to investigate the link between cognitive function, tau pathology, and O‐GlcNAc signaling in an aging mouse model of MetS, agouti KKAy+/−. Male and female C57BL/6, non‐agouti KKAy−/−, and agouti KKAy+/− mice were aged 12–18 months on standard chow diet. Body weight, blood glucose, total cholesterol, and triglyceride were measured to confirm the MetS phenotype. Cognition, sensorimotor function, and emotional reactivity were assessed for each genotype followed by plasma and brain tissue collection for biochemical and molecular analyses. Body weight, blood glucose, total cholesterol, and triglyceride levels were significantly elevated in agouti KKAy+/− mice versus C57BL/6 controls and non‐agouti KKAy−/−. Behaviorally, agouti KKAy+/− revealed impairments in sensorimotor and cognitive function versus age‐matched C57BL/6 and non‐agouti KKAy−/− mice. Immunoblotting demonstrated increased phosphorylated tau accompanied with reduced O‐GlcNAc protein expression in hippocampal‐associated dorsal midbrain of female agouti KKAy+/− versus C57BL/6 control mice. Together, these data demonstrate that impaired cognitive function and AD‐related pathology are associated with reduced O‐GlcNAc signaling in aging MetS KKAy+/− mice. Overall, our study suggests that interaction of tau pathology with O‐GlcNAc signaling may contribute to MetS‐induced cognitive dysfunction in aging.

Cognitive dysfunction and increased phosphorylated tau are associated with reduced O‐GlcNAc signaling in an aging mouse model of metabolic syndrome

Thiamme2-G, a Novel O-GlcNAcase Inhibitor, Reduces Tau Hyperphosphorylation and Rescues Cognitive Impairment in Mice

Metabonomic profiles delineate potential role of glutamate-glutamine cycle in db/db mice with diabetes-associated cognitive decline

Chronic hyperglycemia induces tau hyperphosphorylation by downregulating OGT-involved O-GlcNAcylation in vivo and in vitro.

Age-related alterations in the metabolic profile in the hippocampus of the senescence-accelerated mouse prone 8: a spontaneous Alzheimer's disease mouse model.

High-Fat Diet-Induced Diabetic Conditions Exacerbate Cognitive Impairment in a Mouse Model of Alzheimer's Disease Via a Specific Tau Phosphorylation Pattern

The MET growth signaling complex drives Alzheimer’s Disease-associated brain pathology in aged Shugoshin 1 mouse cohesinopathy model

Analysis of Neuronal Nitric Oxide Synthase Expression and Increasing Astrogliosis in the Brain of Senescence-Accelerated-Prone 8 Mice

Dementia Is Induced via the AGEs/Iba1/iNOS Pathway in Aged KK-Ay/Tajcl Mice

Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice

Global Metabolic Shifts in Age and Alzheimer's Disease Mouse Brains Pivot at NAD+/NADH Redox Sites

Mitochondrial damage-induced abnormal glucose metabolism with ageing in the hippocampus of APP/PS1 mice

Impaired Glucose Tolerance and Reduced Plasma Insulin Precede Decreased AKT Phosphorylation and GLUT3 Translocation in the Hippocampus of Old 3xTg-AD Mice.

Increased Ratio of Global O-GlcNAcylation to Tau Phosphorylation at Thr212 Site is Associated with Better Memory Function in Patients with Type 2 Diabetes

Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress

Effects of age and dietary methionine restriction on cognitive and behavioural phenotypes in the rTg4510 model of frontotemporal dementia

Molecular Signatures of Neurodegenerative Diseases Identified by Proteomic and Phosphoproteomic Analyses in Aging Mouse Brain

Obesity in Aging Exacerbates Blood Brain Barrier Disruption and Neuroinflammation Leading to Synaptic Plasticity Deficit and Cognitive Decline in Mice

Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice.

Altered Hippocampal Glutamatergic Neurotransmission and Cognitive Impairment in APP Knock-In Mice

Defining the Dynamic Regulation of O-GlcNAc Proteome in the Mouse Cortex---the O-GlcNAcylation of Synaptic and Trafficking Proteins Related to Neurodegenerative Diseases